Clifton's Xylem Inc. sued by Xylem Group for trademark infringement
CLIFTON Two months after its trio of tech branches became independent publicly traded companies a City-based defense contractor became the target of a lawsuit alleging copyright infringement.
View ArticleShoe-thrown-at-rahul-gandhi-in-uttarakhand-poll-rally
Shoe misses target; Congress leader heard requesting police not to beat up offender.
View ArticlePatent plaintiffs target Facebook as IPO approaches
As it prepares for one of the biggest IPOs ever, Facebook is coming under the same fierce attacks being waged against other big technology companies: patent lawsuits.
View ArticleAlnylam Says USPTO Upholds Claims in Liver Cancer Drug Patent
Alnylam Pharmaceuticals this week announced that the US Patent and Trademark Office has upheld certain claims within a company patent covering the use of siRNAs against kinesin spindle protein, the...
View ArticleAdGooroo Report Uncovers Who’s Beating Amazon in Paid Search
CHICAGO----AdGooroo today released a complimentary report showing how major retailers such as Target, Toys "R" Us and Victoria's Secret outperformed Amazon in paid search engine marketing in specific...
View ArticleAvista investment to help Matrix strike oil in algae
Seattle-based Matrix Genetics is spinning out of Target Growth and launching its business of developing biofuels made from algae.
View ArticleSpotify Takes on iTunes with New Target Gift Cards, Global Growth
Swedish music streaming service, Spotify, and T-Mobile's parent company, Deutsche Telekom, partnered up to bring music to German consumers. Deutsche Telekom is the first German telecommunications...
View ArticleDenver Patent Office targets opening date in fall of 2013, to hire 125
The new U.S. Patent and Trademark Office in downtown Denver has a target opening date of October or November 2013 and should employ about 125 people, most of them local hires, USPTO Chief of
View ArticleLatest News:
Africa, one of the least tapped markets in the world, has become the target of local IT companies that are eagerly eyeing the continent for business opportunities.
View ArticleCytrx Reaches Patient Enrollment Target In Global Phase 2b Clinical Trial...
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, announced that enrollment of 140 evaluable patients has been completed in the Company's global Phase 2b...
View Article
